Records containing: Medullary Thyroid Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-08-13Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTC
-
CLINICAL_TRIALS study record update · 2021-02-18An ex Vivo Study to Purify Amyloid Fibrils and Solve Their 3D Structures Using Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal Amyloidosis
-
CLINICAL_TRIALS study record update · 2020-11-04Diagnostic Value of 18F-Fluorocholine PET/CT for the Detection of Medullary Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2020-10-19An Open-Label Study of Rovalpituzumab Tesirine in Subjects With Delta-Like Protein 3-Expressing Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-07-2768Ga-DOTATATE Imaging in Neuroendocrine Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-05-22Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients
-
CLINICAL_TRIALS study record update · 2017-05-02A Phase I, Randomized, Open-label, Single-center Study to Assess the Pharmacokinetics of Vandetanib (CAPRELSA) in Healthy Subjects When a Single Oral Dose of Vandetanib 300 mg is Administered Alone and in Combination With Omeprazole or Ranitidine
-
CLINICAL_TRIALS study record update · 2016-12-12An Initial Study of Lithium in Patients With Medullary Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2016-09-07The Use of Lu177 in the Treatment of Progressive and Unresectable Metastatic Medullary Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2016-08-31Effectiveness of Risk Minimisation Interventions for Vandetanib in Canada
-
CLINICAL_TRIALS study record update · 2016-04-25Mono Centre, Open Label Proof of Concept Study SOM230 in Progressive Medullary Thyroid Cancer Patients and the Combination With RAD001 Upon Progression
-
CLINICAL_TRIALS study record update · 2014-11-24A Randomized,Int.,Open-Label Phase III Study to Assess the Effect of a Patient Outreach Program on the Percentage of Time Patients With Locally Advanced or Metastatic MTC Experience Grade 2 or Higher AEs in the First 12 Months of Treatment With Vandetanib
-
CLINICAL_TRIALS study record update · 2013-01-16An Open-Label, Expanded Access Study of Cabozantinib (XL184) in Subjects With Unresectable, Locally Advanced, or Metastatic Medullary Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2012-12-03The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer